Warning: mkdir(): No space left on device in /var/www/tgoop/post.php on line 37

Warning: file_put_contents(aCache/aDaily/post/CIP_USERN/--): Failed to open stream: No such file or directory in /var/www/tgoop/post.php on line 50
CIP, Cancer Immunology Project@CIP_USERN P.369
CIP_USERN Telegram 369
tgoop.com » United States » CIP, Cancer Immunology Project » Telegram web » Post 369
CIP, Cancer Immunology Project
💠Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence.

A New Paper by CIP Members

💠Triple-negative breast cancer (TNBC), which is characterized by the absence of estrogen receptor/progesterone receptor (ER/PR) and human epidermal growth factor receptor 2 (Her2) expressions, has a poorer prognosis compared with non-TNBC breast tumors.

💠Immune checkpoint inhibitors (ICI) have recently gained attention for their possible role in TNBC treatment.

💠Available evidence justifies the application of ICI and chemotherapy combination in the management of metastatic TNBC and early-stage TNBC in neoadjuvant setting.

🌐https://doi.org/10.1016/j.intimp.2021.107876

@cip_usern
@usern_net
www.tgoop.com/CIP_USERN/369
340 views



tgoop.com/CIP_USERN/369
Create:
Last Update:

💠Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence.

A New Paper by CIP Members

💠Triple-negative breast cancer (TNBC), which is characterized by the absence of estrogen receptor/progesterone receptor (ER/PR) and human epidermal growth factor receptor 2 (Her2) expressions, has a poorer prognosis compared with non-TNBC breast tumors.

💠Immune checkpoint inhibitors (ICI) have recently gained attention for their possible role in TNBC treatment.

💠Available evidence justifies the application of ICI and chemotherapy combination in the management of metastatic TNBC and early-stage TNBC in neoadjuvant setting.

🌐https://doi.org/10.1016/j.intimp.2021.107876

@cip_usern
@usern_net

BY CIP, Cancer Immunology Project




Share with your friend now:
tgoop.com/CIP_USERN/369

View MORE
Open in Telegram


Telegram News

Date: |

Clear During a meeting with the president of the Supreme Electoral Court (TSE) on June 6, Telegram's Vice President Ilya Perekopsky announced the initiatives. According to the executive, Brazil is the first country in the world where Telegram is introducing the features, which could be expanded to other countries facing threats to democracy through the dissemination of false content. The best encrypted messaging apps A Telegram channel is used for various purposes, from sharing helpful content to implementing a business strategy. In addition, you can use your channel to build and improve your company image, boost your sales, make profits, enhance customer loyalty, and more. Administrators
from us



Warning: filemtime(): stat failed for aCache/aDaily/post/CIP_USERN/-- in /var/www/tgoop/post.php on line 323

Warning: filemtime(): stat failed for aCache/aDaily/post/CIP_USERN/-- in /var/www/tgoop/post.php on line 324

💠Immune checkpoint inhibitors for triple-negative breast cancer: From immunological mechanisms to clinical evidence.

 CIP, Cancer Immunology Project TG
web: 369
CIP, Cancer Immunology Project.Telegram web
CIP, Cancer Immunology Project Telegram TG Channel
Telegram Updated:
Telegram CIP, Cancer Immunology Project
FROM American